Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection

BACKGROUND: Mass drug administration (MDA) of 20 mg/kg (maximum 1 g in adults) azithromycin for ocular Chlamydia trachomatis (CT) infection is a key component of the WHO trachoma elimination strategy. However, this dose may be suboptimal in Mycoplasma genitalium infection and may encourage emergence...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sex Transm Infect
Main Authors: Harrison, Mark Andrew, Harding-Esch, Emma Michele, Marks, Michael, Pond, Marcus James, Butcher, Robert, Solomon, Anthony W, Zhou, Liqing, Tan, NgeeKeong, Nori, Achyuta V, Kako, Henry, Sokana, Oliver, Mabey, David C W, Sadiq, Syed Tariq
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6860407/
https://ncbi.nlm.nih.gov/pubmed/30981999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/sextrans-2018-053938
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados